CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Open-market sale Principal Accounting Officer sold 1,118 shares at $55.89 ($62,485)
- 4 Open-market sale Principal Accounting Officer sold 991 shares at $54.00 ($53,514)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 1,191 shares (to pay taxes)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Exhibits
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Acquisition or sale completed · Other events
- 8-K Event Shareholder vote results · Other events
- 4 Open-market sale Chief Commercial Officer sold 2,700 shares at an average $48.10 ($129,868)
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Commercial Officer gave up 215 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 821 shares (to pay taxes)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 199 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 986 shares (to pay taxes)
Page 26 of 66 · 1,304 filings